Controlling messaging is a key industry strategy.
“This may be the first time a biotech company has launched a media venture. And while LeapsMag is still small, it raises some big questions. What happens, after all, when a pharmaceutical company starts a magazine? And perhaps more pointedly for science journalists: Is editorial independence even possible when a multinational company is funding the entire operation?”
For full article: https://undark.org/article/leapsmag-bayer-journalism-unbiased/